Peripheral Neuritis Treatment Market to Reach $2.34 Billion by 2029, Growing at a CAGR of 4.9%

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Peripheral Neuritis Treatment Industry Expected To Reach By 2029, Starting From 2025 Levels?

The peripheral neuritis treatment market size has demonstrated robust growth in recent years. It is forecast to grow from $1.84 billion in 2024 to $1.93 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.1%. This historic expansion can be linked to factors such as an increase in healthcare expenditure, the rise in chronic diseases, the escalating burden of conditions related to peripheral neuritis, a higher prevalence rate among diabetic people, and a progressively aging population.

The peripheral neuritis treatment market is projected to experience consistent expansion over the upcoming years. It is anticipated to reach a valuation of $2.34 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 4.9%. This growth during the forecast period can be primarily attributed to an increasing array of treatment alternatives, the expanding elderly demographic, escalating rates of obesity, the widespread presence of HIV/AIDS, the expansion of the generic drug market, and various governmental and healthcare initiatives. Key developments expected in this period include collaborations and partnerships, advancements in technology, a surge in launches of diabetic peripheral neuritis treatment products, a heightened emphasis on personalized medicine, the development of non-pharmacological treatments, and the integration of digital health solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21254&type=smp

What Are The Top Growth Drivers Impacting The Peripheral Neuritis Treatment Market Outlook?

The increasing occurrence of diabetes is projected to fuel expansion in the peripheral neuritis treatment market moving forward. Diabetes is a chronic health condition where the body struggles to maintain appropriate blood sugar (glucose) levels. This surge in diabetes cases can be attributed to elements like inactive lifestyles, poor dietary habits, excessive weight, an aging demographic, and inherited susceptibility. Treatment for peripheral neuritis aids individuals with diabetes by alleviating nerve discomfort, decreasing inflammation, and boosting nerve functionality, thereby contributing to an enhanced quality of life and the prevention of related complications. As an illustration, the American Diabetes Association, a US-based non-profit body, reported in November 2023 that approximately 25.5 million individuals in the U.S. had received a diabetes diagnosis in 2022, representing 7.6% of the overall populace. Consequently, the increasing incidence of diabetes is a key factor propelling the expansion of the peripheral neuritis treatment market.

What Are The Major Segment Categories Driving The Peripheral Neuritis Treatment Market Growth?

The peripheral neuritis treatmentmarket covered in this report is segmented –

1) By Treatment Type: Pharmacological Therapies; Non Pharmacological Therapies

2) By Drug Class: Anti-Depressants; Anticonvulsants; Local Anesthesia; Analgesics; Steroids; Other Drug Classes

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Drug Stores

4) By Application: Diabetic Peripheral Neuropathy; Chemotherapy-Induced Peripheral Neuropathy; Idiopathic Peripheral Neuropathy; Other Applications

Subsegments:

1) By Pharmacological Therapies: Pain Relievers (Analgesics); Antidepressants; Anticonvulsants; Topical Medications

2) By Non-Pharmacological Therapies: Physical Therapy; Transcutaneous Electrical Nerve Stimulation (TENS); Acupuncture; Lifestyle And Dietary Modifications

Which Market Trends Are Creating New Opportunities In The Peripheral Neuritis Treatment Industry?

Leading companies in the peripheral neuritis treatment market are focusing on the development of innovative treatments, such as magnetic peripheral nerve stimulation (mPNS) treatment, to improve nerve regeneration and lessen neuropathic pain. Magnetic peripheral nerve stimulation (mPNS) treatment is defined as a non-invasive neuromodulation technique that utilizes magnetic fields to stimulate peripheral nerves, thereby helping to manage pain, foster nerve regeneration, and enhance motor function in conditions like neuropathy and musculoskeletal disorders. For instance, in January 2024, Neuralace Medical Inc., a US-based medical equipment manufacturing company, announced that Axon Therapy (mPNS), intended for the treatment of chronic painful diabetic neuropathy (PDN), received approval from the Food and Drug administration, a US-based government agency. This therapy offers a swift, pain-free, and non-invasive method for pain relief. Clinical trials demonstrated a 72.3% responder rate at Day 30 and an 81.4% responder rate at Day 90, underscoring its effectiveness in reducing both pain and numbness. This approval signifies a significant stride in pain management, offering patients an alternative to traditional treatments without the common side effects of medication.

Who Are The Primary Competitors In The Global Peripheral Neuritis Treatment Market?

Major companies operating in the peripheral neuritis treatment market are Pfizer Inc., Johnson & Johnson (J&J), AstraZeneca Plc, Novartis AG, GSK plc, Takeda Pharmaceuticals & Co. Ltd., Eli Lilly and Co., Mallinckrodt Pharmaceuticals plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc., Dr Reddys Laboratories Ltd., Cipla Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Daiichi Sankyo Co. Ltd., Glenmark Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/peripheral-neuritis-treatment-global-market-report

How Is Peripheral Neuritis Treatment Market Demand Varying Across Different Regions?

North America was the largest region in the peripheral neuritis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral neuritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Peripheral Neuritis Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21254&type=smp

Browse Through More Reports Similar to the Global Peripheral Neuritis Treatment Market 2025, By The Business Research Company

Neuralgia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

Neuropathic Pain Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Neurotrophic Keratitis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurotrophic-keratitis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795